Our mission: To translate scientific discovery into clinical trials by understanding and proving new disease-specific treatment options for children with cancer
Our 2023 Wilms Tumor and Rhabdomyosarcoma Nanocourse, scheduled for August 7-11th, still has four spots available for Rhabdomyosarcoma families. If you are interested in learning more about this intensive research experience visit: https://t.co/fNX9HuOyml
It is with grieving hearts that we announce the passing of our beloved Board Member Richard Levick. Richard was a staunch advocate of our mission and a dear friend. Charles shares his personal thoughts here: https://t.co/olG8WKaxTJ #cctdi#childhoodcancerresearch#levick
In 2020 and 2021, Starr Children's Fund gave grants to Dr. Charles Keller at the Children's Cancer Therapy Development Institute for their work in finding better treatment options for pediatric cancer through genetic research!
cc-TDI would like to extend our support to all of those effected by childhood cancer. We are continuing to research in your honor so that one-day all childhood cancers are universally survivable. #internationalchildhoodcancerday#childhoodcancer#cctdi
We are thrilled to recognize the Megan's Mission Foundation for their recent $100,000 grant award supporting rhabdomyosarcoma research at cc-TDI.
A link to our press release can be found here: https://t.co/BsTLoXmdBU #rhabdomyosarcomaresearch
Wishing you all love and comfort this Valentines Day! Still struggling to find a meaningful last-minute gift for you loved one? Consider giving your heart to cc-TDI by making a donation in support of our research mission! https://t.co/lV1az8qRqd #givingbackchildhood#cctdi
Thank you to Shelby Sallee for nominating us to be a recipient of FCM Cares’ Holiday Giveback in which $3,228 was raised in support of cancer research. Shelby designated us in memory of her sister Rachel who passed in 2007 from rhabdomyosarcoma.
#childhoodcancerresearch#cctdi
We're excited to share our microscopic computed tomography (microCT) experts with the CLEE “sea creature” science program at @PortlandStateUn. We have published in this area lightly (https://t.co/InK77ypaC2), but working with Annie and Jason take us to a deeper level. #cctdi
We recently recieved a $100,000 grant to further study Ewing sarcoma treatment options thanks to generous support from Golf Fights Cancer. This award, honoring Pete Fox, allows us to continue addressing a pressing need in relapsed Ewing sarcoma patients. #thankyou#ewingsarcoma
Megan's Mission Coffee is now available in K cups thanks to our friends at Live Life Coffee Beans! $5 of each bag (or box) supports rhabdo research at cc-tdi in memory of Megan! https://t.co/YGTWceQs1V
Thank you @LylaNFoundation for their $100,000 grant supporting #DIPG research. This award funds the development of an antibody-drug conjugate (ADC) for DIPG, a universally fatal childhood brain cancer accounting for roughly 16% of pediatric central nervous system tumors.
Make a year-end gift that truly matters. Our current blog post has a heartfelt parents perspective on supporting cc-TDI's mission. A link to the post can be found here: https://t.co/Kbu68tKCOh Thank you to Amy for allowing us to highlight your story. #cctdi
Today our collaborator Tristan Cates from @ChampionsOncol1 visited. Champions Oncology and their team (Iman Habib, and now Stefano Cairo) have done so much to help us develop clinical trial concepts from preclinical testing partnerships. #childhoodcancer#cctdi
Exciting progress is being made at our new lab! This week another big transformation will occur when drywall is installed. Thank you @rhconstco and @ZGFArchitects for their unwavering leadership and support! #MovingTheFuture#cctdi#childhoodcancerresearch
Today is #GIVINGTUESDAY, will you join the movement?
We're asking you to join us TODAY towards raising $10,000 for our new laboratory. All gifts make a lasting impact on our research. Thank you for allowing our team to continue our mission! https://t.co/41OxGTujYf
We’re thrilled to announce exciting progress on our Myoepithelial Carcinoma Biology & EWSR1 Orphan Cancers Drug Discovery Research Program! https://t.co/jpvfytLhFx
For additional information on MEC and how you can get involved visit: https://t.co/cB1gQKWOdP.
#curemec#cctdi
Can you be the hero of this story?
Our amazing IVIS-3D has just reached the end of it’s useful life! Can you help us replace the instrument? https://t.co/LSwnnP1FmE
With this critical instrument, more drugs will be validated to move to human clinical trials - faster! #cctdi
Join Dr. Keller and worldwide collaborators illuminating the role of SMARCA2/4 in childhood alveolar rhabdomyosarcoma by targeted protein degradation with ACBI1. https://t.co/hujmnOWQor